News & Views
Owen Mumford Awarded New Supply Agreement
Feb 26 2010
One of the UK’s leading manufacturers of medical devices for diabetes, Owen Mumford has signed a new three-year supply agreement with Sanofi Aventis for the supply of the Autopen 24 reusable insulin pen for use with
Sanofi Aventis’ insulin cartridges, which will then be supplied to in excess of 60 different countries.
Adam Mumford, Sales & Marketing Director at Owen Mumford, said: “This new agreement with Sanofi Aventis is a strong endorsement of the ease of use and effectiveness of Autopen 24 in assisting patients in the management of their diabetes, acknowledged by healthcare professionals and patients alike. Sanofi Aventis wants to provide maximum patient choice in the selection of the most appropriate insulin pen to suit individual needs and our partnership helps them achieve this goal."
Digital Edition
ILM 49.5 July
July 2024
Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...
View all digital editions
Events
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia
Jul 31 2024 Chengdu, China
ACS National Meeting - Fall 2024
Aug 18 2024 Denver, CO, USA
Aug 25 2024 Copenhagen, Denmark